The Swiss bank Credit Suisse says it may face a “highly significant” loss in the first quarter due to an unnamed American hedge fund client defaulting on margin calls.
In a statementExternal link issued on Monday, the bank said: “While at this time it is premature to quantify the exact size of the loss resulting from this exit, it could be highly significant and material to our first quarter results”.
A margin call is a request from a broker to add more money to an account to cover potential losses. Following the failure of the hedge fund to meet these margin commitments, Credit Suisse and a number of other banks are in the process of exiting these positions, the Swiss bank said.
Credit Suisse said it would provide an update on the matter in “due course”.
Its share price ended the day down 13.8% on the Swiss stock exchange.
Latest blow
Earlier, Japanese lender Nomura Holdings Inc. also warned of a “significant” potential loss from an unnamed US client.
According to various international media, the US hedge fund is Archegos Capital Management, which was founded by Bill Hwang.
The Swiss financial regulator, Finma, said on Monday that Credit Suisse had made it aware of its involvement in an “international hedge fund case” involving “several banks and locations internationally”.
The potential loss is the latest blow to Credit Suisse, which was hit by the recent Greensill scandal. The Swiss bank this month closed around $10 billion of supply-chain finance funds that bought notes from Greensill.
More
More
Credit Suisse and Nomura warn of losses after Archegos-linked sell-off
This content was published on
Credit Suisse finds itself embroiled in a second collapsed financial scheme in the space of weeks.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
Junior Credit Suisse bankers to get $20,000 ‘lifestyle’ bonus
This content was published on
Credit Suisse says it will give more junior members of its capital markets and deal businesses a $20,000 “lifestyle” allowance.
This content was published on
Credit Suisse and GAM Investment Management are two Swiss actors caught up in the collapse of financial services group Greensill Capital.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.